May 27 |
Will IO Biotech (NASDAQ:IOBT) Spend Its Cash Wisely?
|
May 23 |
IO Biotech to Present at Jefferies Global Healthcare Conference
|
May 14 |
IO Biotech GAAP EPS of -$0.30 beats by $0.05
|
May 14 |
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
|
Apr 24 |
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Apr 15 |
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
|
Apr 9 |
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
|
Apr 5 |
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
|
Mar 7 |
IO Biotech Inc (IOBT) Reports Year-End Financial Results and Progress in Clinical Trials
|
Mar 6 |
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
|